carbapenems has been researched along with Blood Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Feng, S; Han, M; Jiang, E; Mi, Y; Wang, J; Xiao, Z; Zhang, F; Zhang, T; Zhao, Y; Zhen, S; Zhu, X | 1 |
| Dou, Q; Hu, Y; Huang, Z; Li, J; Liu, J; Tao, X; Wang, H; Zou, M | 1 |
| Fortunato, S; Lambelet, P; Leonildi, A; Menichetti, F; Simonetti, F; Stefanelli, A; Tascini, C; Vettori, C | 1 |
| Biggs, MJ; Bradley, CW; Garvey, MI; Gill, MJ; Holden, E | 1 |
| Abi Hanna, P; Aliyu, S; Allignol, A; Alvarez-Moreno, C; Arora, A; Bagga, R; Barman, P; Bhattarai, B; Carvalho, MJ; Correa, AL; Delgado-Ramirez, MA; El-Banna, T; El-Bouseary, M; Feghali, R; Harbarth, S; Hassan, B; Iregbu, K; Kanj, SS; Kaur, A; Khanal, B; Le, TAT; Marimuthu, K; Munera, MI; Ovosi, JO; Owusu-Ofori, AK; Phukan, C; Saad, H; Saha, SK; Saleemi, MA; Sengupta, S; Sharma, L; Stewardson, AJ; Tran, TTN; Uddin, J; Uwaezuoke, NS; Valderrama-Beltrán, SL; Walsh, TR; Zahra, R | 1 |
| Kirby, T | 1 |
| Bertaina, A; Ciceri, F; Cudillo, L; Girmenia, C; Lombardini, L; Pastore, D; Piciocchi, A; Pisapia, G; Rambaldi, A; Rossolini, GM; Scimè, R; Severino, A; Sica, S; Viscoli, C | 1 |
| Benyamini, N; Fineman, R; Finkelstein, R; Oren, I; Rowe, JM; Sprecher, H; Zuckerman, T | 1 |
| Hino, M; Kanamaru, A; Masaoka, T; Nakagawa, Y; Ohta, K; Ohyashiki, K; Suzuki, K; Tamura, K; Urabe, A | 1 |
| Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K | 1 |
| Azuma, R; Harada, H; Mori, H; Niikura, H; Omine, M; Sakai, H; Sanada, M; Shimamoto, K | 1 |
2 trial(s) available for carbapenems and Blood Diseases
| Article | Year |
|---|---|
Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Female; Fever; Hematologic Diseases; Humans; Male; Meropenem; Neutropenia; Prospective Studies; Thienamycins; Treatment Outcome; Young Adult | 2013 |
Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy.
Topics: Adult; Aged; Algorithms; Carbapenems; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Remission Induction; Salvage Therapy; Treatment Failure; Treatment Outcome | 2006 |
9 other study(ies) available for carbapenems and Blood Diseases
| Article | Year |
|---|---|
Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors | 2023 |
Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Carbapenems; Child; Child, Preschool; China; Female; Hematologic Diseases; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Young Adult | 2019 |
Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Female; Gentamicins; Hematologic Diseases; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Rectum | 2017 |
Selection of carbapenem-resistant Pseudomonas aeruginosa in a haematology unit?
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Transmission, Infectious; Hematologic Diseases; Hospital Departments; Hospitals, University; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Selection, Genetic; United Kingdom; Water Microbiology | 2018 |
Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Developing Countries; Enterobacteriaceae Infections; Female; Hematologic Diseases; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies | 2019 |
Souha Kanj.
Topics: Carbapenems; Cohort Studies; Drug Resistance, Microbial; Enterobacteriaceae Infections; Hematologic Diseases; Hospitalization; Humans; Poverty; Prospective Studies | 2019 |
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy.
Topics: Adolescent; Adult; Aged; Allografts; Autografts; Carbapenems; Drug Resistance, Bacterial; Female; Hematologic Diseases; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation | 2015 |
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Female; Gastrointestinal Tract; Gentamicins; Hematologic Diseases; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pilot Projects; Stem Cell Transplantation | 2011 |
[Clinical evaluation of biapenem for febrile neutropenia in patients with hematological disorders].
Topics: Anemia, Aplastic; Carbapenems; Fever; Hematologic Diseases; Humans; Infusions, Intravenous; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Myelodysplastic Syndromes; Neutropenia; Thienamycins; Treatment Outcome | 2007 |